LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 1 | H14 | 72 | hr | 513 | 527 | 10537 | 0.0500 | 0.0060 |
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 2 | H14 | 72 | hr | 513 | 459 | 10386 | 0.0442 | -0.0255 |
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 3 | H14 | 72 | hr | 513 | 478 | 10494 | 0.0455 | -0.0163 |
MCF 10A | SNS-032 | 10 | uM | LJP6 | 1 | H13 | 72 | hr | 513 | 363 | 10537 | 0.0344 | -0.0764 |
MCF 10A | SNS-032 | 10 | uM | LJP6 | 2 | H13 | 72 | hr | 513 | 374 | 10386 | 0.0360 | -0.0704 |
MCF 10A | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 513 | 484 | 10494 | 0.0461 | -0.0134 |
MCF 10A | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 513 | 381 | 10537 | 0.0362 | -0.0661 |
MCF 10A | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 513 | 293 | 10386 | 0.0282 | -0.1213 |
MCF 10A | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 513 | 380 | 10494 | 0.0362 | -0.0668 |
MCF 10A | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 513 | 444 | 10537 | 0.0421 | -0.0328 |
MCF 10A | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 513 | 370 | 10386 | 0.0356 | -0.0727 |
MCF 10A | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 513 | 469 | 10494 | 0.0447 | -0.0205 |
MCF 10A | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 513 | 501 | 10537 | 0.0475 | -0.0056 |
MCF 10A | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 513 | 408 | 10386 | 0.0393 | -0.0516 |
MCF 10A | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 513 | 553 | 10494 | 0.0527 | 0.0172 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 513 | 583 | 10537 | 0.0553 | 0.0296 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 513 | 614 | 10386 | 0.0591 | 0.0421 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 513 | 569 | 10494 | 0.0542 | 0.0239 |
MCF 10A | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 513 | 489 | 10537 | 0.0464 | -0.0111 |
MCF 10A | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 513 | 572 | 10386 | 0.0551 | 0.0252 |
MCF 10A | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 513 | 514 | 10494 | 0.0490 | 0.0003 |
MCF 10A | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 513 | 584 | 10537 | 0.0554 | 0.0300 |
MCF 10A | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 513 | 470 | 10386 | 0.0452 | -0.0201 |
MCF 10A | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 513 | 631 | 10494 | 0.0601 | 0.0485 |
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 513 | 3819 | 10537 | 0.3624 | 0.5846 |